2022 General Investor Relations Presentation
Operating performance
Taste & Wellbeing
Sales in CHF million
EBITDA
720
in CHF million
786
3,593
+7.6%
LFL growth
3,398
FY 2020
21.2%
22.1%
EBITDA Margin
FY 2021
21.9%
Comparable EBITDA Margin 22.4%
*Like-for-like: excludes the impact of currency, acquisitions and disposals
Givaudan
Sales of CHF 3,593 million, an increase of 7.6% on a like-for-like
basis and of 5.7% in Swiss francs
EBITDA of CHF 786 million, increased from CHF 720 million in 2020
Acquisition and restructuring costs of CHF 20 million, compared to
CHF 32 million in 2020, largely related to the integration of the
recently acquired companies and ongoing optimisation of the
manufacturing footprint
EBITDA margin of 21.9% compared to 21.2% in 2020. The
comparable EBITDA margin was 22.4% versus 22.1% in 2020
As % of sales
2022 General Investor Relations presentation
February 2022
41View entire presentation